Response Genetics Inc RGDXQ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.01
- Market Cap
- $38.80
- Volume/Avg
- 77,002 / 77,002
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Response Genetics Inc develops and sells diagnostic tests. It provides molecular- and biomarker-based tests and services which enables physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor and inform cancer treatment. The group generates revenue from providing Biopharma Services, Clinical Services, and Discovery Services, of which majority of the revenue is derived from providing Biopharma Services. Biopharma services provide companies with customized solutions for patient stratification and treatment selection through molecular- and biomarker-based testing services, customized assay development and trial design consultation. The firm operates in the US and internationally and generates prime revenue from the US.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 100
- Website
- http://www.responsegenetics.com
Valuation
|
Metric
|
RGDXQ
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
RGDXQ
|
|---|---|
Quick Ratio | 2.64 |
Current Ratio | 2.86 |
Interest Coverage | −61.26 |
Quick Ratio
RGDXQ
Profitability
|
Metric
|
RGDXQ
|
|---|---|
Return on Assets (Normalized) | −50.00% |
Return on Equity (Normalized) | −85.23% |
Return on Invested Capital (Normalized) | −60.49% |
Return on Assets
RGDXQ
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Kjzkjrsrb | Vcpr | $212.9 Bil | |
DHR
| Danaher Corp | Mrzqzvnfts | Nhymby | $177.5 Bil | |
IQV
| IQVIA Holdings Inc | Wltmxmd | Tgdyy | $42.6 Bil | |
A
| Agilent Technologies Inc | Wxxxtsgvf | Tbpqm | $41.1 Bil | |
IDXX
| IDEXX Laboratories Inc | Sdqbzswrsj | Kvvdct | $40.8 Bil | |
MTD
| Mettler-Toledo International Inc | Ykzhxzzcs | Dpwhcrg | $26.6 Bil | |
ICLR
| Icon PLC | Rdyykznf | Whzlmhv | $24.7 Bil | |
ILMN
| Illumina Inc | Qgrjkjyj | Xxsmwx | $19.3 Bil | |
WAT
| Waters Corp | Tqgcfrqt | Vrsb | $19.0 Bil | |
LH
| Laboratory Corp of America Holdings | Qphpssqfn | Ftjxln | $17.1 Bil |